Toshiaki Shirai, PhD

Assisitant Professor
Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi
Chuo, Yamanashi, Japan

Toshiaki Shirai is an Assistant Professor at the University of Yamanashi. He earned his Ph.D. from the University of Yamanashi in 2016. His research interests focus on elucidating the role of platelets in cancer. He has investigated the impact of the platelet activation receptor CLEC-2 on cancer progression and has developed methods to inhibit cancer progression by regulating platelet counts through TPO. Currently, he is working on developing safe anti-platelet therapies to combat cancer progression and cancer-associated thrombosis.

Presentation(s):

• OC 09.5 - CLEC-2 mediates ferric chloride-induced platelet activation and attenuates ferroptosis in endothelial cells.

  Saturday, June 22, 2024
  14:00 – 14:15 ICT

• OC 12.4 - Cancer-associated fibroblasts promote venous thrombosis by releasing podoplanin-positive extracellular vesicles.

  Sunday, June 23, 2024
  10:15 – 10:30 ICT